Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types (2)
Select products & services
Select solutions
Active Filters (2)
Clear All
1 - 12 of 41 Results
Sort by:
Best Match
Form
New York Supplemental Informed Consent
This informed consent is necessary before any samples from New York can be collected.
Form
Informed Consent Form - NEVADA
This informed consent is necessary before any samples from Nevada can be collected.
Form
Roadmap2Rare Diagnostic Requisition - Cardiomyopathy
This is a form for Roadmap2Rare Diagnostic Requisition - Cardiomyopathy
Form
Ultragenyx Pharmaceutical Requisition Form Sponsored MPS Testing
This is a form for Ultragenyx pharmaceutical - Sponsored MPS Testing
Form
Roadmap2Rare Diagnostic Requisition - Muscle Disorders
This is a form for Roadmap2Rare Diagnostic Requisition - Roadmap2Rare Diagnostic Requisition - Muscle Disorders
Form
Roadmap2Rare Diagnostic Requisition - Lysosomal Storage Disorders
This is a form for Roadmap2Rare Diagnostic Requisition - Roadmap2Rare Diagnostic Requisition - Lysosomal Storage Disorders
Form
Data release form
This form helps clients and patients request for retrieval of their raw data
Form
Newborn screening follow-up requisition
This form is useful to order follow-up testing once newborn screening is completed
Case Study
Assessment of MYC-driven progression of small cell lung cancer
Researchers at Huntsman Cancer Center use GEMM and the Quantum microCT system for evaluating small cell lung cancer.
Case Study
NIH NCATS case study: using accelerated screening research for SARS-CoV-2 drug repurposing candidates
Find out how the NCATS team was able to quickly screen 3,384 molecular entities and narrow them down to a field of 25 quality "hits" capable of disrupting SARS-Cov-2 S1 protein:ACE2 receptor binding in this case study.
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.